Which has the lower trailing P/E, BIO or PODD?

PODD has the lower trailing P/E: BIO trades at 46.26 and PODD at 25.17. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, BIO or PODD?

Over the past five years, PODD grew revenue faster — BIO at a 0.29% CAGR versus PODD at 25.13%.

Is BIO or PODD more profitable?

PODD runs the higher net margin — BIO at 8.59% versus PODD at 12.29%.

How have BIO and PODD total returns compared?

Over the past 10 years, BIO delivered 8.88% and PODD delivered 12.38% annualized total return. Past performance doesn't predict future results.

Bio-Rad Laboratories, Inc. (BIO) vs Insulet Corp. (PODD)

A side-by-side comparison of Bio-Rad Laboratories, Inc. and Insulet Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.

BIO

Bio-Rad Laboratories, Inc.

$10.27B

$381.67HealthcareDelayed quote: Sep 24, 2026, 12:10 PM EDT

PODD

Insulet Corp.

$9.33B

$134.67HealthcareDelayed quote: Sep 24, 2026, 12:10 PM EDT

Total return — BIO vs PODD

growth of $100 · dividends reinvested · last 10y

BIO +131.8% (+8.8%/yr)PODD +224.3% (+12.5%/yr)PODD compounded faster over this window

BIO PODD

BIO vs PODD: by the numbers

•BIO is the larger company ($10.27B vs $9.33B market cap).
•PODD trades at the lower trailing earnings multiple (25.17 vs 46.26 P/E), one valuation lens rather than an overall verdict.
•PODD converts more revenue to profit (12.29% vs 8.59% net margin).
•PODD grew revenue faster over the past five years (25.13% vs 0.29% CAGR).

Metrics side by side

Valuation

Metric	BIO	PODD
P/E ratio	46.26	25.17
Forward P/E	39.59	20.71
P/S ratio	3.97	3.05
P/B ratio	1.43	6.56
EV / EBITDA	28.65	15.68
FCF yield	3.44%	3.20%

Profitability

Metric	BIO	PODD
Gross margin	51.90%	71.08%
Operating margin	9.08%	16.89%
Net margin	8.59%	12.29%
ROE	3.10%	26.39%
ROIC	1.54%	16.04%

Growth (annualized)

Metric	BIO	PODD
Revenue CAGR (5Y)	0.29%	25.13%
EPS CAGR (5Y)	-26.27%	99.91%
FCF CAGR (5Y)	-9.65%	N/A
Total return CAGR (5Y)	-14.74%	-14.94%

Frequently asked

Which has the lower trailing P/E, BIO or PODD?: PODD has the lower trailing P/E: BIO trades at 46.26 and PODD at 25.17. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, BIO or PODD?: Over the past five years, PODD grew revenue faster — BIO at a 0.29% CAGR versus PODD at 25.13%.
Is BIO or PODD more profitable?: PODD runs the higher net margin — BIO at 8.59% versus PODD at 12.29%.
How have BIO and PODD total returns compared?: Over the past 10 years, BIO delivered 8.88% and PODD delivered 12.38% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BIO analysis Full PODD analysis Interactive comparison tool

Dig into the metrics

Bio-Rad Laboratories P/E ratio Insulet P/E ratio Bio-Rad Laboratories ROE Insulet ROE Bio-Rad Laboratories operating margin Insulet operating margin Bio-Rad Laboratories revenue growth Insulet revenue growth Bio-Rad Laboratories free cash flow Insulet free cash flow

Bio-Rad Laboratories & Insulet appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.